CytomX Therapeutics Inc (CTMX)

17.51
NASDAQ : Health Care
Prev Close 17.57
Day Low/High 17.28 / 17.74
52 Wk Low/High 9.85 / 20.02
Avg Volume 261.20K
Exchange NASDAQ
Shares Outstanding 36.87M
Market Cap 647.76M
EPS -1.60
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

CytomX Therapeutics To Announce Second Quarter 2017 Financial Results And Provide Mid-Year Update

CytomX Therapeutics To Announce Second Quarter 2017 Financial Results And Provide Mid-Year Update

Teleconference Scheduled for August 7, 2017, at 5:00 p.m. ET

Commit To Buy CytomX Therapeutics At $12.50, Earn 17.9% Annualized Using Options

Investors considering a purchase of CytomX Therapeutics Inc shares, but tentative about paying the going market price of $13.51/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the November put at the $12.50 strike, which has a bid at the time of this writing of 95 cents.

CytomX Therapeutics Enters Oversold Territory (CTMX)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

CytomX Announces Management Team Changes

Stocks Lower as Crude Slump Weighs on Energy Sector

Stocks Lower as Crude Slump Weighs on Energy Sector

Stocks snap a holding pattern to pull lower on Monday afternoon as a crude oil slump weighS on the energy sector.

Biotechs Remain the Best Place For Stock Picking

Biotechs Remain the Best Place For Stock Picking

Biotech companies show more energy than the rest of the market Monday.

Dow, Nasdaq Rise as FBI's Comey Confirms Probe of Russia's Election Interference

Dow, Nasdaq Rise as FBI's Comey Confirms Probe of Russia's Election Interference

Stocks move mostly higher on Monday morning as a hearing on Russia's involvement in the U.S. election begins on Capitol Hill.

Biotech Premarket Movers: CytomX, Aevi, Esperion

Biotech Premarket Movers: CytomX, Aevi, Esperion

CytomX Therapeutics, Aevi Genomic Medicine and Esperion Therapeutics were among the biotech stock movers in premarket trading on Monday.

CytomX Soars on Bristol-Myers Partnership

CytomX Soars on Bristol-Myers Partnership

Shares of the biotech, which researches cancer drugs, were up nearly 30% ahead of market's open.

Stock Futures Slip After G20 Meeting Raises Fears of Protectionism

Stock Futures Slip After G20 Meeting Raises Fears of Protectionism

Stock futures move mostly lower on Monday after the weekend's G20 meeting raises fears over protectionist attitudes among the world's largest economies.

CytomX Therapeutics Announces Teleconference And Webcast To Provide Corporate Update

Teleconference Scheduled for Monday, March 20, 2017 at 8:00 a.m. ET

TheStreet Quant Rating: D (Sell)